Supplementary Table 1.docx (13.52 kB)
Supplementary Table 1. Nivolumab in Metastatic Renal Cell Carcinoma: Results from the Turkish Oncology Group Kidney Cancer Consortium Database
dataset
posted on 2021-11-02, 15:56 authored by Emre Yekedüz, İsmail Ertürk, Deniz Tural, Nuri Karadurmuş, Serdar Karakaya, Mutlu Hızal, Rukiye Arıkan, Çağatay Arslan, Hakan Taban, Ahmet Küçükarda, Nihan Şentürk Öztaş, Özlem Nuray Sever, Gökhan Uçar, Orçun Can, Mehmet Ali Nahit Şendur, Umut Demirci, Saadettin Kılıçkap, İrfan Çiçin, Berna Öksüzoğlu, Mustafa Özgüroğlu, Yüksel ÜrünSupplementary Table 1. Nivolumab in Metastatic Renal Cell Carcinoma: Results from the Turkish Oncology Group Kidney Cancer Consortium Database
Previous Systemic Treatment According to Nivolumab Line